Genentech's Covid-fighting drug in short supply just two months after FDA greenlight

Plateauing vaccination rates and a surge of Covid infections has left Covid patients, rheumatoid arthritis patients and some cancer patients competing for a dwindling supply of the drug.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news